Generation of three iPSC lines with inducible systems to be used in Angelman syndrome research.
Stem Cell Res
; 78: 103454, 2024 Aug.
Article
em En
| MEDLINE
| ID: mdl-38843694
ABSTRACT
The neurodevelopmental disorder Angelman syndrome (AS) has an incidence of 115.000 live births and is caused by absence of UBE3A protein, showing imprinted gene expression in the brain. Imprinted genes are controlled by differentially methylated regions resulting in parent-of-origin dependent gene expression. Two iPS cell lines derived from patients with AS and one healthy control iPSC line were used to integrate a 3rd generation reverse tetracycline transactivator protein (rtTA3) into the AAVS1 locus on chromosome 19. The rtTA allows tetracycline-dependent activation of an inducible promoter that can be introduced at a position of interest in the cell lines described here.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Síndrome de Angelman
/
Células-Tronco Pluripotentes Induzidas
Limite:
Humans
Idioma:
En
Revista:
Stem Cell Res
/
Stem cell research (Online)
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Alemanha